Full Text
Cost-Utility Analysis of Recommended Ranibizumab Regimen for Age-Related Macular Degeneration in China

Abstract

Authors

X. Ying S. Feng W. Wu J. Chang

Back to Volume 17, Issue 7
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×